Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Enigmatic Ladies of the Rings: How Cohesin Dysfunction Affects Myeloid Neoplasms Insurgence.

Pezzotta A, Mazzola M, Spreafico M, Marozzi A, Pistocchi A.

Front Cell Dev Biol. 2019 Feb 27;7:21. doi: 10.3389/fcell.2019.00021. eCollection 2019.

2.

NIPBL: a new player in myeloid cell differentiation.

Mazzola M, Deflorian G, Pezzotta A, Ferrari L, Fazio G, Bresciani E, Saitta C, Ferrari L, Fumagalli M, Parma M, Marasca F, Bodega B, Riva P, Cotelli F, Biondi A, Marozzi A, Cazzaniga G, Pistocchi A.

Haematologica. 2019 Jul;104(7):1332-1341. doi: 10.3324/haematol.2018.200899. Epub 2019 Jan 10.

3.

HDAC8 regulates canonical Wnt pathway to promote differentiation in skeletal muscles.

Ferrari L, Bragato C, Brioschi L, Spreafico M, Esposito S, Pezzotta A, Pizzetti F, Moreno-Fortuny A, Bellipanni G, Giordano A, Riva P, Frabetti F, Viani P, Cossu G, Mora M, Marozzi A, Pistocchi A.

J Cell Physiol. 2019 May;234(5):6067-6076. doi: 10.1002/jcp.27341. Epub 2018 Sep 24.

4.

A Novel Method for Isolation of Pluripotent Stem Cells from Human Umbilical Cord Blood.

Monti M, Imberti B, Bianchi N, Pezzotta A, Morigi M, Del Fante C, Redi CA, Perotti C.

Stem Cells Dev. 2017 Sep 1;26(17):1258-1269. doi: 10.1089/scd.2017.0012. Epub 2017 Jun 4.

PMID:
28583028
5.

Renal progenitors derived from human iPSCs engraft and restore function in a mouse model of acute kidney injury.

Imberti B, Tomasoni S, Ciampi O, Pezzotta A, Derosas M, Xinaris C, Rizzo P, Papadimou E, Novelli R, Benigni A, Remuzzi G, Morigi M.

Sci Rep. 2015 Mar 6;5:8826. doi: 10.1038/srep08826.

6.

Effects of MCP-1 inhibition by bindarit therapy in a rat model of polycystic kidney disease.

Zoja C, Corna D, Locatelli M, Rottoli D, Pezzotta A, Morigi M, Zanchi C, Buelli S, Guglielmotti A, Perico N, Remuzzi A, Remuzzi G.

Nephron. 2015;129(1):52-61. doi: 10.1159/000369149. Epub 2014 Dec 17.

7.

Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement.

Locatelli M, Buelli S, Pezzotta A, Corna D, Perico L, Tomasoni S, Rottoli D, Rizzo P, Conti D, Thurman JM, Remuzzi G, Zoja C, Morigi M.

J Am Soc Nephrol. 2014 Aug;25(8):1786-98. doi: 10.1681/ASN.2013050450. Epub 2014 Feb 27.

8.

╬▓-arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury.

Buelli S, Rosan├▓ L, Gagliardini E, Corna D, Longaretti L, Pezzotta A, Perico L, Conti S, Rizzo P, Novelli R, Morigi M, Zoja C, Remuzzi G, Bagnato A, Benigni A.

J Am Soc Nephrol. 2014 Mar;25(3):523-33. doi: 10.1681/ASN.2013040362. Epub 2013 Dec 26.

9.

Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injury.

Cassis P, Gallon L, Benigni A, Mister M, Pezzotta A, Solini S, Gagliardini E, Cugini D, Abbate M, Aiello S, Rocchetta F, Scudeletti P, Perico N, Noris M, Remuzzi G.

Kidney Int. 2012 May;81(9):903-18. doi: 10.1038/ki.2011.473. Epub 2012 Feb 8.

10.

Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.

Morigi M, Galbusera M, Gastoldi S, Locatelli M, Buelli S, Pezzotta A, Pagani C, Noris M, Gobbi M, Stravalaci M, Rottoli D, Tedesco F, Remuzzi G, Zoja C.

J Immunol. 2011 Jul 1;187(1):172-80. doi: 10.4049/jimmunol.1100491. Epub 2011 Jun 3.

11.

Propionyl-L-carnitine prevents early graft dysfunction in allogeneic rat kidney transplantation.

Azzollini N, Cugini D, Cassis P, Pezzotta A, Gagliardini E, Abbate M, Arduini A, Peschechera A, Remuzzi G, Noris M.

Kidney Int. 2008 Dec;74(11):1420-8. doi: 10.1038/ki.2008.399. Epub 2008 Aug 13.

12.

Fractalkine and CX3CR1 mediate leukocyte capture by endothelium in response to Shiga toxin.

Zanchi C, Zoja C, Morigi M, Valsecchi F, Liu XY, Rottoli D, Locatelli M, Buelli S, Pezzotta A, Mapelli P, Geelen J, Remuzzi G, Hawiger J.

J Immunol. 2008 Jul 15;181(2):1460-9.

13.

Effect of seliciclib (CYC202, R-roscovitine) on lymphocyte alloreactivity and acute kidney allograft rejection in rat.

Pezzotta A, Mister M, Monteferrante G, Cassis L, Azzollini N, Aiello S, Satta M, Benigni A, Remuzzi G, Noris M.

Transplantation. 2008 May 27;85(10):1476-82. doi: 10.1097/TP.0b013e31816f240c.

PMID:
18497689
14.

Role of thymic- and graft-dependent mechanisms in tolerance induction to rat kidney transplant by donor PBMC infusion.

Cavinato RA, Casiraghi F, Azzollini N, Mister M, Pezzotta A, Cassis P, Cugini D, Perico N, Remuzzi G, Noris M.

Kidney Int. 2007 Jun;71(11):1132-41. Epub 2007 Mar 21.

15.

DnIKK2-transfected dendritic cells induce a novel population of inducible nitric oxide synthase-expressing CD4+CD25- cells with tolerogenic properties.

Aiello S, Cassis P, Cassis L, Tomasoni S, Benigni A, Pezzotta A, Cavinato RA, Cugini D, Azzollini N, Mister M, Longaretti L, Thomson AW, Remuzzi G, Noris M.

Transplantation. 2007 Feb 27;83(4):474-84.

PMID:
17318081
16.

Adeno-associated virus-mediated CTLA4Ig gene transfer protects MHC-mismatched renal allografts from chronic rejection.

Benigni A, Tomasoni S, Turka LA, Longaretti L, Zentilin L, Mister M, Pezzotta A, Azzollini N, Noris M, Conti S, Abbate M, Giacca M, Remuzzi G.

J Am Soc Nephrol. 2006 Jun;17(6):1665-72. Epub 2006 Apr 26.

17.

Effect of a novel immunosuppressant, ST1959, on the immune system and renal allograft survival in rats.

Pezzotta A, Mister M, Cravedi P, Azzollini N, Cassis L, Ruggiero V, DeSantis R, Carminati P, Remuzzi G, Noris M.

Transplantation. 2005 Jul 27;80(2):231-6.

PMID:
16041268
18.

Dendritic cells genetically engineered with adenoviral vector encoding dnIKK2 induce the formation of potent CD4+ T-regulatory cells.

Tomasoni S, Aiello S, Cassis L, Noris M, Longaretti L, Cavinato RA, Azzollini N, Pezzotta A, Remuzzi G, Benigni A.

Transplantation. 2005 May 15;79(9):1056-61.

PMID:
15880043
19.

Pretransplant donor peripheral blood mononuclear cells infusion induces transplantation tolerance by generating regulatory T cells.

Cavinato RA, Casiraghi F, Azzollini N, Cassis P, Cugini D, Mister M, Pezzotta A, Aiello S, Remuzzi G, Noris M.

Transplantation. 2005 May 15;79(9):1034-9.

PMID:
15880039
20.

ACE inhibition limits chronic injury of kidney transplant even with treatment started when lesions are established.

Noris M, Mister M, Pezzotta A, Azzollini N, Cassis P, Benigni A, Gagliardini E, Perico N, Remuzzi G.

Kidney Int. 2003 Dec;64(6):2253-61.

21.

Diverse effects of increasing lisinopril doses on lipid abnormalities in chronic nephropathies.

Ruggenenti P, Mise N, Pisoni R, Arnoldi F, Pezzotta A, Perna A, Cattaneo D, Remuzzi G.

Circulation. 2003 Feb 4;107(4):586-92.

PMID:
12566371
22.

Thymic microchimerism correlates with the outcome of tolerance-inducing protocols for solid organ transplantation.

Noris M, Cugini D, Casiraghi F, Azzollini N, De Deus Viera Moraes L, Mister M, Pezzotta A, Cavinato RA, Aiello S, Perico N, Remuzzi G.

J Am Soc Nephrol. 2001 Dec;12(12):2815-26.

23.

Combined treatment with mycophenolate mofetil and an angiotensin II receptor antagonist fully protects from chronic rejection in a rat model of renal allograft.

Noris M, Azzollini N, Pezzotta A, Mister M, Benigni A, Marchetti G, Gagliardini E, Perico N, Remuzzi G.

J Am Soc Nephrol. 2001 Sep;12(9):1937-46.

24.

Peripheral donor leukocytes prolong survival of rat renal allografts.

Noris M, Azzollini N, Mister M, Pezzotta A, Piccinini G, Casiraghi F, Cugini D, Perico N, Orisio S, Remuzzi G.

Kidney Int. 1999 Sep;56(3):1101-12.

25.

Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism.

Amuchastegui SC, Azzollini N, Mister M, Pezzotta A, Perico N, Remuzzi G.

J Am Soc Nephrol. 1998 Oct;9(10):1948-55.

Supplemental Content

Loading ...
Support Center